Purdue Sues To Halt Sandoz's Generic OxyContin Plans
Purdue Pharma LP and Grunenthal GmbH on Wednesday hit rival Sandoz Inc. with a suit in New York federal court, seeking to block Sandoz's plans to market a generic reformulated version...To view the full article, register now.
Already a subscriber? Click here to view full article